---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-053463"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:56:42.965735+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# CEO and CMO waive 2023 and 2024 bonuses to reduce liabilities

## Summary
- CEO Eric Schlorff and CMO Dr. Kevin Chung agreed to waive earned bonuses for 2023 and 2024 fiscal years.
- Bonus release agreements aim to reduce company liabilities; consideration is continued employment at current pay.
- Agreements include a release of claims against the company for compensation-related matters.
- Dollar amount of waived bonuses is not disclosed in the filing.

## SEC filing metadata
- accession: 0001213900-25-053463
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000121390025053463/0001213900-25-053463-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000121390025053463/ea0245443-8k_seastar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-053463
- JSON: https://secwatch.observer/filing/0001213900-25-053463.json
- Plain text: https://secwatch.observer/filing/0001213900-25-053463.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.